Skip to main content
. 2016 Jul;28(87):267–274.

Table 1.

Patient characteristic and EBER association with various clinicopathological parameters

Patient or tumour Characteristic Total (n=51) EBER Positive EBER Negative P Value
Sex Male 36 (70.58%) 22 (43.14%) 14 (27.45%) 0.6071
Female 15 (29.42%) 08 (15.69%) 07 (13.73%)
Age 21-40 yr 19 (37.26%) 11 (21.57%) 08 (15.69%) 0.4146
41-60 yr 26 (50.98%) 14 (27.45%) 12 (23.53%)
61-70 yr 06 (11.77%) 05 (9.81%) 01 (1.96%)
Smoked food User 30 (58.83%) 28 (54.91%) 02 (3.93%) 0.0234
Non user 21 (41.18%) 14 (27.45%) 07 (13.73%)
Cigarette Smoking User 30 (58.83%) 18 (35.30%) 12 (23.57%) 0.0269
Non user 21 (41.18%) 06 (11.77%) 15 (29.42%)
Alcohol User 30 (58.83%) 16 (31.38%) 14 (27.45%) 0.1927
Non user 21 (41.18%) 15 (29.42%) 06 (11.77%)
Ethnicity Naga 30 (58.83%) 24 (47.06%) 06 (11.77%) 0.0158
Non-Naga 21 (41.18%) 10 (19.61%) 11 (21.57%)
Cervical
Lymph Node
Metastasis present 37 (72.55%) 22 (43.14%) 15 (29.42%) 0.8808
Metastasis absent 14 (27.45%) 08 (15.69%) 06 (11.77%)
Histological types Non-keratinizing undifferentiated 45 (88.24%) 25 (49.02%) 20 (39.22%) 0.3806
Non-keratinizing differentiated 06 (11.77%) 05 (9.81%) 01 (1.96%)